Published in Circulation on October 30, 2001
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol (2007) 3.96
Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation (2002) 2.93
Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. Circulation (2009) 2.20
A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial). Eur Heart J Cardiovasc Imaging (2015) 1.44
Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int (2013) 1.29
Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts. Heart (2003) 1.18
Targeted therapy to prevent progression of calcific aortic stenosis. Circulation (2004) 1.17
Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler Thromb Vasc Biol (2009) 1.16
Retracted C-reactive protein in aortic valve disease. Cardiovasc Ultrasound (2006) 1.12
C-reactive protein in degenerative aortic valve stenosis. Cardiovasc Ultrasound (2006) 1.11
Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes (2009) 1.04
Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment. Arterioscler Thromb Vasc Biol (2008) 1.01
Calcific aortic valve disease: Is it another face of atherosclerosis? Indian Heart J (2015) 1.00
Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Arch Intern Med (2008) 1.00
Serotonin receptors and heart valve disease--it was meant 2B. Pharmacol Ther (2011) 0.99
Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both? Heart (2006) 0.99
Potential drug targets for calcific aortic valve disease. Nat Rev Cardiol (2014) 0.98
Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins. Heart (2005) 0.91
Aortic stenosis: medical and surgical management. Heart (2005) 0.91
Aortic stenosis. BMJ (2005) 0.90
The medical management of valvar heart disease. Heart (2002) 0.90
Ongoing clinical trials of the pleiotropic effects of statins. Vasc Health Risk Manag (2005) 0.89
Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination. Mol Cell Biochem (2007) 0.88
Three dimensional volume quantification of aortic valve calcification using multislice computed tomography. Heart (2003) 0.87
Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag (2006) 0.86
Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments. EPMA J (2011) 0.85
Pathogenesis of aortic stenosis: not just a matter of wear and tear. Am J Cardiovasc Dis (2011) 0.85
The bicuspid aortic valve and its relation to aortic dilation. Clinics (Sao Paulo) (2010) 0.83
Visualizing novel concepts of cardiovascular calcification. Trends Cardiovasc Med (2013) 0.83
Lipid-lowering therapy in older persons. Arch Med Sci (2015) 0.82
Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease. J Cardiothorac Surg (2014) 0.82
The effect of statins therapy in aortic stenosis: Meta-analysis comparison data of RCTs and observationals. Data Brief (2016) 0.81
Insights into aortic sclerosis and its relationship with coronary artery disease. J Am Heart Assoc (2014) 0.80
Pleiotropic effects of the HMG-CoA reductase inhibitors. Int J Gen Med (2011) 0.80
Risk factors for progression of calcific aortic stenosis and potential therapeutic targets. Int J Angiol (2008) 0.79
Mechanisms of calcification in aortic valve disease: role of mechanokinetics and mechanodynamics. Curr Cardiol Rep (2013) 0.79
Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients. Heart Vessels (2010) 0.78
Is it time for medical therapy for aortic valve disease? Expert Rev Cardiovasc Ther (2004) 0.77
New concepts in valvular hemodynamics: implications for diagnosis and treatment of aortic stenosis. Can J Cardiol (2007) 0.77
Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive? Indian Heart J (2009) 0.76
The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality. J Heart Valve Dis (2012) 0.76
Management of hyperlipidemia with statins in the older patient. Clin Interv Aging (2006) 0.76
Effect of hydroxymethylglutaryl coenzyme-a reductase inhibitors on the long-term progression of rheumatic mitral valve disease. Circulation (2010) 0.76
Recent advances in medical treatment and percutaneous, transapical and surgical interventions in aortic-valve stenosis. F1000 Med Rep (2009) 0.75
Reduced Long-Term Relative Survival in Females and Younger Adults Undergoing Cardiac Surgery: A Prospective Cohort Study. PLoS One (2016) 0.75
Is there a role of statins in the prevention of aortic biological prostheses degeneration. Cardiovasc Ultrasound (2006) 0.75
Predictors of echocardiographic progression in patients with mild aortic stenosis. Korean Circ J (2011) 0.75
Management of asymptomatic severe aortic stenosis. Curr Cardiol Rev (2009) 0.75
Role of serum high density lipoprotein levels and functions in calcific aortic valve stenosis progression. Int J Clin Exp Med (2015) 0.75
APOE alleles are not associated with calcific aortic stenosis. Heart (2006) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2002) 0.75
Is there evidence for statins in the treatment of aortic valve stenosis? World J Cardiol (2017) 0.75
Effect of Rosuvastatin on Bovine Pericardial Aortic Tissue Valve Calcification in a Rat Subdermal Implantation Model. Korean Circ J (2017) 0.75
Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med (1999) 7.59
Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation (2001) 4.85
Association between myeloperoxidase levels and risk of coronary artery disease. JAMA (2001) 3.74
Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA (2000) 3.24
Safety of long-term lamotrigine in epilepsy. Epilepsia (1997) 2.92
Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis. JAMA (2001) 2.56
Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance. Pharmacoepidemiol Drug Saf (1997) 2.33
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet (2001) 2.23
Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann Intern Med (2000) 2.16
Mechanisms of hemolysis with mitral prosthetic regurgitation. Study using transesophageal echocardiography and fluid dynamic simulation. J Am Coll Cardiol (1996) 2.14
Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation (2001) 2.12
Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med (1992) 2.11
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption. Circulation (1999) 1.88
Association of body fat distribution and cardiovascular risk factors in children and adolescents. Circulation (1999) 1.87
Complete bundle branch block as an independent predictor of all-cause mortality: report of 7,073 patients referred for nuclear exercise testing. Am J Med (2001) 1.84
The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol (1999) 1.65
Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice. BMJ (2000) 1.62
Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging. J Am Coll Cardiol (1996) 1.61
Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension (1995) 1.61
Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (1999) 1.60
Prescription-event monitoring of 10,401 patients treated with fluvoxamine. Br J Psychiatry (1994) 1.58
Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation (2001) 1.58
Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene. Ann Intern Med (1996) 1.56
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. BMJ (1988) 1.55
A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients. J Hum Hypertens (2006) 1.51
Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism. Eur Heart J (2000) 1.48
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol (1996) 1.47
Overweight, fat patterning, and cardiovascular disease risk factors in black and white boys. J Pediatr (1999) 1.41
Current medical management of valvular heart disease. Cleve Clin J Med (2001) 1.40
Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease. Am J Med (2000) 1.39
Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy. Am Heart J (1996) 1.39
A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Saf (1997) 1.38
Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol (1996) 1.34
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol (1995) 1.31
The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol (1998) 1.31
Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest (1986) 1.28
Sexual maturation and obesity in 9- and 10-year-old black and white girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (1994) 1.26
Prognostic significance of exercise-induced left bundle-branch block. JAMA (1998) 1.23
The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism (1985) 1.23
Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol (1998) 1.23
Usefulness of impaired chronotropic response to exercise as a predictor of mortality, independent of the severity of coronary artery disease. Am J Cardiol (2000) 1.23
Effects of anesthetic technique on myocardial wall motion abnormalities during abdominal aortic surgery. J Cardiothorac Vasc Anesth (1997) 1.22
Myocardial wall velocity assessment by pulsed Doppler tissue imaging: characteristic findings in normal subjects. Am Heart J (1996) 1.18
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. Am J Cardiol (1998) 1.18
Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol (1997) 1.18
Two-dimensional electrophoresis of human plasma apolipoproteins. Clin Chem (1984) 1.17
Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest (1990) 1.16
Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol (1993) 1.16
Physician use of an ambulatory medical record system: matching form and function. Proc AMIA Symp (1998) 1.13
Caseous calcification of the mitral annulus: an underappreciated variant. Heart (2004) 1.12
Delayed systolic blood pressure recovery after graded exercise: an independent correlate of angiographic coronary disease. J Am Coll Cardiol (1999) 1.11
Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol (1996) 1.11
Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol (2000) 1.10
Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol (2001) 1.10
Newer antidepressants: a comparison of tolerability in general practice. Br J Gen Pract (1999) 1.09
Improvement in mitral regurgitation after aortic valve replacement. Am J Cardiol (1997) 1.09
Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway. Biochim Biophys Acta (2000) 1.07
Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease. Am J Cardiol (1997) 1.07
Calculation of mitral regurgitant orifice area with use of a simplified proximal convergence method: initial clinical application. J Am Soc Echocardiogr (2001) 1.05
Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol (1999) 1.03
Cardiac rehabilitation participation patterns in a large, tertiary care center: evidence for selection bias. J Cardiopulm Rehabil (2000) 1.02
Mechanical properties of myxomatous mitral valves. J Thorac Cardiovasc Surg (2001) 1.01
Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol (2000) 1.00
Myxomatous mitral valve chordae. I: Mechanical properties. J Heart Valve Dis (2001) 0.97
Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation (1994) 0.97
The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. Am J Med (1999) 0.94
Analysis of the apoC-II gene in apoC-II deficient patients. Biochem Biophys Res Commun (1984) 0.94
United Kingdom experience with alendronate and oesophageal reactions. Br J Gen Pract (1998) 0.94
Differentiation of constrictive pericarditis from restrictive cardiomyopathy by Doppler transesophageal echocardiographic measurements of respiratory variations in pulmonary venous flow. J Am Coll Cardiol (1993) 0.93
Quantification of mitral regurgitation by automated cardiac output measurement: experimental and clinical validation. J Am Coll Cardiol (1998) 0.93
Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol (2000) 0.93
Localization of needle tip with color doppler during pericardiocentesis: In vitro validation and initial clinical application. J Am Soc Echocardiogr (2001) 0.92
Sex and race differences in cardiovascular disease risk factor changes in schoolchildren, 1975-1990: the Princeton School Study. Am J Public Health (1999) 0.92
Serum glutathione in adolescent males predicts parental coronary heart disease. Circulation (1999) 0.91
Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study). Am J Cardiol (1992) 0.91
Quantification of mitral regurgitation by the proximal convergence method using transesophageal echocardiography. Clinical validation of a geometric correction for proximal flow constraint. Circulation (1995) 0.91
Use of segmental tissue Doppler velocity to quantitate exercise echocardiography. J Am Soc Echocardiogr (1999) 0.90
Independent contribution of myocardial perfusion defects to exercise capacity and heart rate recovery for prediction of all-cause mortality in patients with known or suspected coronary heart disease. J Am Coll Cardiol (2001) 0.90
Bowl-game pulmonary embolism. N Engl J Med (1986) 0.90
Human preproapolipoprotein C-II. Analysis of major plasma isoforms. J Biol Chem (1986) 0.89
Myxomatous mitral valve chordae. II: Selective elevation of glycosaminoglycan content. J Heart Valve Dis (2001) 0.89
A propensity analysis of cigarette smoking and mortality with consideration of the effects of alcohol. Am J Cardiol (2001) 0.89
Prescription-event monitoring: methodology and recent progress. J Clin Epidemiol (1990) 0.89
Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis. Diabetes Care (2000) 0.89
Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia. Biochim Biophys Acta (1989) 0.88
Improvement in right ventricular systolic function after surgical correction of isolated tricuspid regurgitation. J Am Soc Echocardiogr (2000) 0.88
Immediate and long-term outcome of percutaneous mitral valvotomy in patients 65 years and older. Circulation (1992) 0.88
Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleeding. BMJ (2000) 0.88
Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol (1997) 0.88
Relation of serum triglyceride levels to survival after coronary artery bypass grafting. Am J Cardiol (2000) 0.88
Chronotropic response to exercise. Improved performance of ST-segment depression criteria after adjustment for heart rate reserve. Circulation (1996) 0.88
Transesophageal Doppler echocardiography of pulmonary venous flow: a new marker of mitral regurgitation severity. J Am Coll Cardiol (1991) 0.88
Determinants of functional capacity in chronic mitral regurgitation unassociated with coronary artery disease or left ventricular dysfunction. Am J Cardiol (1997) 0.87
Estimation of VLDL cholesterol in hyperlipidemia. Clin Chim Acta (1985) 0.87
In vitro color flow, pulsed and continuous wave Doppler ultrasound masking of flow by prosthetic valves. J Am Coll Cardiol (1987) 0.86
Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents. J Pediatr (1995) 0.86